CareLit · DOI-Nachweis · Pneumologie
Pirfenidone is Efficacious in Patients with Idiopathic Pulmonary Fibrosis (IPF) and Mild Restrictive Disease
DOI 10.1055/s-0036-1572064
Bibliografische Angaben
Nachweis in CareLit
Autor:innenU Costabel, C Albera, WZ Bradford, EA Fagan, I Glaspole, MK Glassberg, E Gorina, D Kardatzke, TE King, L Lancaster, DJ Lederer, SD Nathan, CA Pereira, D Spirig, JJ Swigris, D Valeyre, PW Noble
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: IPF is a progressive, irreversible and fatal disease. Early treatment when lung function is relatively preserved may have beneficial outcomes. Here we investigated the efficacy of pirfenidone (PFD) in patients stratified by mild vs more pronounced restrictive disease as well as by GAP stage. Methods: Efficacy outcomes (FVC, 6MWD, UCSD SOBQ) were analysed at 12 months in patients randomised to PFD 2403…
Zitieren
Zitierempfehlung
U Costabel, C Albera, WZ Bradford, EA Fagan, I Glaspole, MK Glassberg, E Gorina, D Kardatzke, TE King, L Lancaster, DJ Lederer, SD Nathan, CA Pereira, D Spirig, JJ Swigris, D Valeyre, PW Noble (2016) Pirfenidone is Efficacious in Patients with Idiopathic Pulmonary Fibrosis (IPF) and Mild Restrictive Disease. Pneumologie (02). https://doi.org/10.1055/s-0036-1572064
Mit CareLit weiterarbeiten